HbA1c Response to Open-Label (OL) Empagliflozin (EMPA) with Metformin (MET) in Patients with Type 2 Diabetes (T2DM)

被引：0

作者：

Schernthaner, Guntram

Tinahones, Francisco J.

Goetz, Sophia

Lee, Christopher

机构：

来源：

DIABETES | 2017年 / 66卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1288-P

引用

页码：A345 / A346

页数：2

共 50 条

[41] Efficacy and Safety of Vildagliptin in Triple Combination With Metformin Plus Sulfonylurea in Subgroup of Patients With T2DM and Baseline HbA1c
Lukashevich, Valentina
Araga, Mako
Kothny, Wolfgang
DIABETES, 2013, 62 : A294 - A294
[42] Five-Year Population Level Trajectory of HbA1c (AIC) and its Association With Mortality in Patients With Type 2 Diabetes (T2DM)
Paul, Sanjoy K.
Best, Jennie H.
Khunti, Kamlesh
Klein, Kerenaftali
DIABETES, 2012, 61 : A363 - A363
[43] Precision medicine approach improves HbA1c outcomes in T2DM
Tysoe, Olivia
NATURE REVIEWS ENDOCRINOLOGY, 2023, 19 (03) : 129 - 129
[44] Precision medicine approach improves HbA1c outcomes in T2DM
Olivia Tysoe
Nature Reviews Endocrinology, 2023, 19 : 129 - 129
[45] GLYCATED HEMOGLOBIN (HBA1C) CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) TREATED WITH CANAGLIFLOZIN IN A REAL-WORLD SETTING
Lefebvre, P.
Pilon, D.
Robitaille, M.
Lafeuille, M.
Chow, W.
Pfeifer, M.
Duh, M. S.
VALUE IN HEALTH, 2015, 18 (03) : A57 - A57
[46] Vildagliptin is as effective as rosiglitazone in lowering HbA1c but without weight gain in drug-naive patients with type 2 diabetes (T2DM)
Rosenstock, Julio
Baron, Michelle A.
Schweizer, Anja
Mills, David
Dejager, Sylvie
DIABETES, 2006, 55 : A133 - A133
[47] Prevalence of Hemoglobin variants in T2DM through HbA1c assessment
Gupta, S.
Baig, A.
Gupta, S.
Gupta, S.
DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 209
[48] Perception, HbA1c and the Quality of Life of Diabetes Mellitus (T2DM) Patients at RSUD Abdul Azis Singkawang
Faridah, Imaniar Noor
Masyithah, Nurul
Perwitasari, Dyah Aryani
ADVANCED SCIENCE LETTERS, 2017, 23 (12) : 12464 - 12468
[49] Long-Term Clinical Outcomes Associated With LDL-C and HbA1c Goal Achievement in Patients With Type 2 Diabetes Mellitus (T2DM)
Shi, Lizheng
Ye, Xin
Lu, Mei
Wu, Eric Q.
Sharma, Hari
Thomason, Darren
Fonseca, Vivian
DIABETES, 2013, 62 : A392 - A392
[50] Review: HbA1c has low accuracy for prediabetes; lifestyle programs and metformin reduce progression to T2DM
Maki, Dennis G.
ANNALS OF INTERNAL MEDICINE, 2017, 166 (08) : JC41 - JC41

← 1 2 3 4 5 →